Advisory Committee Conflict Of Interest Waivers Get Support From Study
Executive Summary
FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is getting support from an independent review. According to an analysis commissioned by the agency, constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise
You may also be interested in...
FDA Gains No Impartiality Benefit From Conflict-Of-Interest Policy, Advocates Say
Friends of Cancer Research cites an FDA-sponsored study to argue that agency adherence to an advisory committee conflict-of-interest policy that is stricter than required by law does not increase the impartiality of panel members’ recommendations.
FDA Gains No Impartiality Benefit From Conflict-Of-Interest Policy, Advocates Say
Friends of Cancer Research cites an FDA-sponsored study to argue that agency adherence to an advisory committee conflict-of-interest policy that is stricter than required by law does not increase the impartiality of panel members’ recommendations.
Advisory Cmte. Conflict of Interest Waivers Common; Avandia Is High Water Mark
As currently convened, the majority of FDA advisory committee meetings on drugs would likely violate a limit on participation by experts with a financial conflict of interest being considered by Congress